Metagenomi grabs $65m Series A

Metagenomi, a next-generation gene editing company, has secured $65 million in Series A financing.

Metagenomi, a next-generation gene editing company, has secured $65 million in Series A financing. Leaps by Bayer and Humboldt Fund led the round with participation from other investors that included Sozo Ventures, Agent Capital, InCube Ventures and HOF Capital.

Source: Press Release